Home › Funds › Belvedere Trading LLC › CURE

Belvedere Trading LLC position in CURE

Direxion Daily Healthcare Bull 3X ETF

Belvedere Trading LLC reported holding 12,800 shares of CURE (Direxion Daily Healthcare Bull 3X ETF) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 0.01% of its reported portfolio and ranking #48 among its reported holdings. Belvedere Trading LLC has disclosed CURE holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)12.80K sh
Reported value held$1.44M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Belvedere Trading LLC's CURE position evolved

Belvedere Trading LLC first disclosed a stake in CURE in Q4 2023 at 700 shares (US$71K). The position peaked in Q2 2026 at 12,800 shares, worth US$1.4M. Across 5 filings, Belvedere Trading LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 12,800 shares valued at US$1.4M — an increase of 1,900 shares quarter over quarter.. Notable position changes include a 25% increase in Q1 2024 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 700 $71.22K New
Q1 2024 878 $110.14K Add
Q1 2025 3.70K $394.56K New
Q1 2026 10.90K $998.11K New
Q2 2026 12.80K $1.44M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CURE and 13F data

CURE (Direxion Daily Healthcare Bull 3X ETF) is a company whose sector is not yet classified in our data. 21 other funds we track also report a position in CURE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CURE

No other tracked fund reports a position in CURE.

All CURE fund holders →

FAQ

How long has Belvedere Trading LLC held CURE?

Belvedere Trading LLC has disclosed CURE holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

What is Belvedere Trading LLC's current position in CURE?

As of Q2 2026, Belvedere Trading LLC holds 12.80K shares of CURE (Direxion Daily Healthcare Bull 3X ETF), valued at $1.44M, representing 0.01% of its reported portfolio and ranking #48.

Has Belvedere Trading LLC been buying or selling CURE?

In the latest 13F filing (Q2 2026), Belvedere Trading LLC increased its position in CURE. The position peaked in Q2 2026 at 12.80K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.